TLR2 promotes vascular smooth muscle cell chondrogenic differentiation and consequent calcification via the concerted actions of osteoprotegerin suppression and IL …
GL Lee, CC Yeh, JY Wu, HC Lin, YF Wang… - … and Vascular Biology, 2019 - Am Heart Assoc
Objective—Vascular smooth muscle cell (VSMC) transformation to an osteochondrogenic
phenotype is an initial step toward arterial calcification, which is highly correlated with …
phenotype is an initial step toward arterial calcification, which is highly correlated with …
[HTML][HTML] Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway
S Zhou, X Fang, H Xin, W Li, H Qiu, S Guan - PloS one, 2013 - journals.plos.org
Objective Vascular calcification is a common pathobiological process which occurs among
the elder population and in patients with diabetes and chronic kidney disease …
the elder population and in patients with diabetes and chronic kidney disease …
TLR4/NF-κB/Ceramide signaling contributes to Ox-LDL-induced calcification of human vascular smooth muscle cells
Y Song, M Hou, Z Li, C Luo, JS Ou, H Yu, J Yan… - European Journal of …, 2017 - Elsevier
Vascular calcification is a major feature of advanced atherosclerosis and highly associated
with cardiovascular diseases. Oxidized low density lipoprotein (Ox-LDL) has been …
with cardiovascular diseases. Oxidized low density lipoprotein (Ox-LDL) has been …
Increased calcification in osteoprotegerin-deficient smooth muscle cells: dependence on receptor activator of NF-κB ligand and interleukin 6
A Callegari, ML Coons, JL Ricks… - Journal of vascular …, 2014 - karger.com
Objective: Vascular calcification is highly correlated with cardiovascular disease morbidity
and mortality. Osteoprotegerin (OPG) is a secreted decoy receptor for receptor activator of …
and mortality. Osteoprotegerin (OPG) is a secreted decoy receptor for receptor activator of …
RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4–dependent pathway
Vascular calcification commonly associated with several pathologies and it has been
suggested to be similar to bone mineralization. The axis RANKL-OPG (receptor activator of …
suggested to be similar to bone mineralization. The axis RANKL-OPG (receptor activator of …
Nidogen-2 is a novel endogenous ligand of LGR4 to inhibit vascular calcification
Y Chen, C Mao, R Gu, R Zhao, W Li, Z Ma… - Circulation …, 2022 - Am Heart Assoc
Background: Vascular calcification is closely related to the all-cause mortality of
cardiovascular events. Basement membrane protein nidogen-2 is a key component of the …
cardiovascular events. Basement membrane protein nidogen-2 is a key component of the …
Vascular Smooth Muscle LRP6 Limits Arteriosclerotic Calcification in Diabetic LDLR−/− Mice by Restraining Noncanonical Wnt Signals
SL Cheng, B Ramachandran, A Behrmann… - Circulation …, 2015 - Am Heart Assoc
Rationale: Wnt signaling regulates key aspects of diabetic vascular disease. Objective: We
generated SM22-Cre; LRP6 (fl/fl); LDLR−/− mice to determine contributions of Wnt …
generated SM22-Cre; LRP6 (fl/fl); LDLR−/− mice to determine contributions of Wnt …
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin
P Collin-Osdoby - Circulation research, 2004 - Am Heart Assoc
Vascular calcification often occurs with advancing age, atherosclerosis, various metabolic
disorders such as diabetes mellitus and end-stage renal disease, or in rare genetic …
disorders such as diabetes mellitus and end-stage renal disease, or in rare genetic …
Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages
CH Byon, Y Sun, J Chen, K Yuan, X Mao… - … , and vascular biology, 2011 - Am Heart Assoc
Objective—Clinical and experimental studies demonstrate the important roles of vascular
smooth muscle cells (VSMC) in the pathogenesis of atherosclerosis. We have previously …
smooth muscle cells (VSMC) in the pathogenesis of atherosclerosis. We have previously …
[HTML][HTML] TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL
The osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL)
cytokine system, not only controls bone homeostasis, but has been implicated in regulating …
cytokine system, not only controls bone homeostasis, but has been implicated in regulating …
相关搜索
- receptor activator muscle cells
- nf κb muscle cells
- concerted actions rankl induction
- muscle cell rankl induction
- muscle cell concerted actions
- increased calcification muscle cells
- nidogen 2 vascular calcification
- osteoclastic differentiation muscle cells
- modulation of rankl vascular calcification
- muscle cell down regulation
- trail deficiency vascular calcification
- ceramide signaling muscle cells
- muscle cell notch1 rbp
- ox ldl muscle cells
- muscle cell rbp jκ